Details of the Drug Formulations

General Information of Drug (ID: DM5YF4M)

• Drug Name: Droxidopa Drug Info
• Synonyms: droxidopa; 23651-95-8; L-DOPS; Northera; (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid; threo-Dopaserine; 3916-18-5; DOPS; DL-threo-DOPS; L-Threodops; DL-threo-3,4-Dihydroxyphenylserine; DL-threo-Droxidopa; DL-threo-Dihydroxyphenylserine; UNII-J7A92W69L7; SM 5688; CHEBI:31524; Droxidopa (L-DOPS); threo-beta,3-Dihydroxy-DL-tyrosine; EINECS 223-480-5; beta,3-Dihydroxy-DL-tyrosine threo-; BRN 2852792; L-threo-dihydroxyphenylserine; DL-threo-3-(3,4-Dihydroxyphenyl)serine; Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-

Indication

Disease Entry	ICD 11	Status	REF
Chronic fatigue syndrome	8E49	Approved	[1]
Neurogenic orthostatic hypotension	8D87.0Y	Approved	[2]
Pure autonomic failure		Approved	[1]

• Cross-matching ID:
  PubChem CID: 92974
  ChEBI ID: CHEBI:31524
  CAS Number: 23651-95-8
  TTD ID: D0I3RO
  INTEDE ID: DR0552
  ACDINA ID: D00219

Full List of Drug Formulations Containing This Drug

Droxidopa 300 mg capsule

Company	Formulation ID	FDA Description
Lundbeck Pharmaceuticals	F07060	Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 5; Magnesium stearate; Mannitol; Titanium dioxide; Gelatin; Starch, corn

Droxidopa 100 mg capsule

Company	Formulation ID	FDA Description
Lundbeck Pharmaceuticals	F07058	Fd&c blue no. 2; Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Gelatin; Starch, corn

Droxidopa 200 mg capsule

Company	Formulation ID	FDA Description
Lundbeck Pharmaceuticals	F07059	Fd&c blue no. 2; Magnesium stearate; Mannitol; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Gelatin; Starch, corn

References

• [1] Droxidopa FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7391).